The GiveWell Blog

The impact of COVID-19 on GiveWell’s plans

We hope everyone is staying well during these difficult times. We are publishing this blog post to provide a brief update on how the COVID-19 (coronavirus) pandemic impacts our plans.

We are looking into the impact of the pandemic on the organizations we support as well as opportunities to mitigate its effects. We are in the early stages of this work and will update you as we reach conclusions.

We don’t have a new recommendation for donors: our bottom line continues to be to donate to “Grants to recommended charities at GiveWell’s discretion,” which we allocate quarterly to the highest priority need we see.

Read more

Allocation of discretionary funds from Q4 2019

We recently allocated donations made from October through December 2019 to “Grants to recommended charities at GiveWell’s discretion.” We granted $11.9 million to Malaria Consortium’s seasonal malaria chemoprevention program and $1.5 million to Helen Keller International’s vitamin A supplementation program.

We allocate donations to “Grants to recommended charities at GiveWell’s discretion” (discretionary funds) quarterly, according to where we see the highest-priority funding needs. Malaria Consortium’s seasonal malaria chemoprevention (SMC) program and Helen Keller International (HKI)’s vitamin A supplementation (VAS) program had the top-priority needs among our top charities at the time we made this decision.

Malaria Consortium provides preventive anti-malarial medication to young children during the time of year when malaria transmission is highest. HKI supports provision of vitamin A supplements to young children, which reduces their risk of dying of infectious disease.[1] We estimate that the combined discretionary grants to these organizations will save 5,600 lives.[2]

In this post, we discuss:

  • Our process for deciding where to allocate discretionary funds. (More)
    • We share updates on:
      • HKI’s VAS program. (More)
      • Malaria Consortium’s SMC program. (More)
      • SCI Foundation. (More)
    • We also discuss uncertainties in our decision. (More)
  • Our bottom line for donors giving today. (More)

Read more

March 2020 open thread

Our goal with hosting quarterly open threads is to give blog readers an opportunity to publicly raise comments or questions about GiveWell or related topics (in the comments section below). As always, you’re also welcome to email us at info@givewell.org or to request a call with GiveWell staff if you have feedback or questions you’d prefer to discuss privately. We’ll try to respond promptly to questions or comments.

Read more

How did we do in 2019? A preliminary look at our growth.

We see an early indication that GiveWell continued its trajectory of robust donor growth last year. The total value of donations processed by GiveWell increased 30% in 2019.[1]

We’re sharing this data now because we believe it is an informative early update about our growth last year. However, GiveWell-processed donations don’t tell the full story of our impact. Many donors who rely on our research give via our partner organizations or directly to our top charities. Their gifts account for the majority of donations due to our work and are not processed by GiveWell. Information about these gifts is time-consuming to gather and has usually led us to release our metrics data many months after the end of the year. We plan to release a complete 2019 metrics report and assessment of our impact, including donations not processed by GiveWell, later this year.

Here’s what we know so far, based on the nearly complete information we have about donations we processed:

  • We processed $54.1 million in donations in 2019. Sixty-five percent of this amount was restricted to our recommended charities and 35% was unrestricted, which we may use to support GiveWell’s operations.
  • Support from donors giving $10,000 to $100,000 comprised the largest proportion of our growth (35%).[2]
  • Returning donors who gave more than last year made up 75% of our growth in funds donated (excluding anonymous donations).[3]
  • We believe that the majority of our growth was organic and would have occurred without any outreach and marketing efforts from GiveWell, although we can attribute some to specific outreach and marketing initiatives.[4]

We’re encouraged by this growth and excited to write about it. We also discuss below some ways that GiveWell-processed donations could be a misleading indicator of our overall impact.

Read more

Introducing our new Managing Director: Dr. Neil Buddy Shah

I’m very excited to announce that Dr. Neil Buddy Shah is joining GiveWell as Managing Director starting this summer.

We’re beyond thrilled that Buddy, a leader in the global health and development space, has chosen to be part of our team at this exciting time. We have significantly expanded our research focus over the past few years to identify high-impact giving opportunities beyond our current top charities list. In addition to working with me to set our strategy generally, a core component of Buddy’s work will be pushing our research and funding expansion forward by leading GiveWell’s efforts to learn from and contribute to the broader international development community.

He is exceptionally qualified to do so. Buddy has spent the last eight years as Founding Partner and CEO of IDinsight, a group GiveWell has worked closely with and supported through our Incubation Grants program. We’re confident that IDinsight will continue to do great work over the coming years.

Buddy is now heading the leadership transition process at IDinsight. He expects to join GiveWell around July. Welcome to the team!

Read more

Why it’s important to think through all of the factors that influence a charity’s impact

Charity evaluation is rarely straightforward. Many factors, within a charity’s control or outside of it, can influence the impact a charity has.

This blog post will highlight a case that illustrates how thinking through these factors can lead to surprising information that changes our understanding of a charity’s impact.

Summary

GiveWell recommended a grant to Results for Development (R4D) in May 2016 for its recently-launched program to increase access to pneumonia treatments for children in Tanzania. We thought this program was promising enough to potentially join our short list of GiveWell top charities once we had more information on its impact.

Expanded access to treatments is a factor in reducing child mortality from pneumonia, but not the only factor. We ultimately want to know not just whether more pneumonia treatments are available in Tanzania, but whether fewer children die of pneumonia as a result of R4D’s work. We expect the program to best achieve this impact if pneumonia patients visit health clinics with treatments in stock and are diagnosed and treated correctly.

We learned as we followed R4D’s work that there was limited information available on the accuracy of clinicians’ pneumonia diagnoses. We initially guessed that clinicians were diagnosing pneumonia accurately around 80 percent of the time. R4D collected data on diagnostic accuracy and we learned that the rate of accurate pneumonia diagnosis was actually 18 percent. This caused our estimate of the program’s impact to fall, though it remains in the range that we look for in potential top charities.

This finding highlights why it’s important to think through all of the factors along the path from a charity’s activities to its ultimate impact; if we had just considered whether more treatments were available, we would have missed this part of the story. We’re excited to continue following R4D’s work because of the role it has played in collecting this information to date and our expectation that it will continue collecting information that allows us to estimate its impact on the availability of pneumonia treatments across Tanzania. We expect to consider R4D as a potential future top charity.

In this post, we discuss:

  • The background for GiveWell’s grant to R4D (More)
  • Our plans for assessing the impact of R4D’s program (More)
  • Approaches to measuring R4D’s impact (More)
  • Lessons from this work (More)

Read more